Chemotherapy-Free ‘Cancer Vaccine’ Moves From Mice to Human Trials

By SF Gate. A recent Stanford cancer study that cured 97 percent of mice from tumors has now moved on to soliciting human volunteers for a new cutting-edge medical trial.

The trial is part of a gathering wave of research into immunotherapy, a type of treatment that fights cancer by using the body’s immune system to attack tumors.

“Getting the immune system to fight cancer is one of the most recent developments in cancer,” Dr. Ronald Levy, a Stanford oncology professor who is leading the study, told SFGATE. “People need to know that this is in its early days and we are still looking for safety and looking to make this as good as it can be.”

The treatment is not a true vaccine that creates lasting immunity, but it does feature a vaccine-like injection carrying two immune stimulators that activate the immune system’s T cells to eliminate tumors throughout the body.

Each test subject receives a low dose of radiation plus two rounds of the injected agents, Levy said. No chemotherapy is involved. (Read more from “Chemotherapy-Free ‘Cancer Vaccine’ Moves From Mice to Human Trials” HERE)


Breast Cancer Patients May Avoid Chemo in Future Thanks to Innovative Study by Royal College of Surgeons

By DublinLive. A study from Ireland’s leading medical college has suggested that future cancer patients could avoid chemotherapy using a mathematical formula.

Researchers at the Royal College Of Surgeons say they have come up with the formula, which could predict how chemo would affect patients with an aggressive form of breast cancer.

The RCSI’s Jochen Prehnd saod: “At the moment the only form of drug treatment available to patients with triple-negative breast cancer is chemotherapy. (Read more from “Breast Cancer Patients May Avoid Chemo in Future Thanks to Innovative Study by Royal College of Surgeons” HERE)

Follow Joe Miller on Twitter HERE and Facebook HERE.